ARCHIVES

UPCI To Lead Clinical Trials Of Eli Lilly’s Oncology Agents.

This article is from The Cancer Letter archive.

Vol. 27 No. 27 | July 6, 2001

Download PDF Visit The Full Archive

Related Articles

Bad News for EPO Products Brings FDA Scrutiny, Payment Curbs. FDA Issues Alert to Doctors.

February 23, 2007

Community Assn. Plan Meeting In DC On Program Problems

November 29, 1974

Reorganization Of Making Program Is Proposed

June 22, 1990

FDA Clears Rapid Test For Aspergillus Infection

May 30, 2003

NCS Heeds Bloch’s Plea, To Consider Establishing Separate PDQ-Like System For General Public Use

December 7, 1984

Second-Generation CML Drugs Show Promise For Frontline

December 26, 2008